Sweden· SE-20041220000153
Cancidas 50 mg Pulver till infusionsvätska, lösning
A medicinal product containing caspofungin, registered in Sweden by Merck Sharp & Dohme Limited.
Checked against Swedish Medical Products Agency (Sweden) on
Informational only — not a medical device.
The record
At a glance
Swedish Medical Products Agency (Sweden)- Active substance
- Caspofungin
- Manufacturer
- Merck Sharp & Dohme Limited
- Country
- Sweden (SE)
- ATC code
- —
- Reimbursed
- Not published by this register
- Source register
- Swedish Medical Products Agency (Sweden)
- Last checked
- August 27, 2026
Packs & prices · 1
- se_varunummer20041220000153
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Caspofungin in 15 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- SpainCANCIDAS 50 mg POLVO PARA CONCENTRADO PARA SOLUCION PARA PERFUSIONMerck Sharp & Dohme B.V.
- FinlandCancidasMerck Sharp & Dohme B.V.
- United KingdomCancidas 50mg powder for concentrate for solution for infusion vialsMerck Sharp & Dohme (UK) Ltd
- BelgiumCancidas 50 mgMerck Sharp & Dohme
- PolandCancidasMerck Sharp & Dohme B.V.
- IrelandCancidas 50 mg powder for concentrate for solution for infusionMerck Sharp & Dohme BV
- IcelandCancidasMerck Sharp & Dohme B.V.*
- NorwayCancidasMerck Sharp & Dohme B.V. (1)
Authorised across Europe · EMA
The same active substance is authorised in 30 EEA countries. Names it is sold under:
- Austria · Caspofungin Anfarm, Caspofungin Fresenius Kabi
- Belgium · Caspofungin Fresenius Kabi, Caspofungin Sandoz
- Bulgaria · Каспофунгин Ромфарм
- Cyprus · Caspofungin Demo, Caspofungin Sapiens
- Czechia · Caspofungin Demo
- Germany · Caspofungin Demo, Caspofungin Eberth
- Denmark · Casmyg, Caspofungin "sandoz"
- Estonia · Caspofungin Sandoz
- Spain · Caspofungin Demo, Caspofungina Demo
- Finland · Caspofungin Demo S.A., Caspofungin Lorien
- France · Caspofungine Hikma, Caspofungine Lorien
- United Kingdom (Northern Ireland) · Caspofungin, Caspofungin Demo Pharmaceutical Industry
- Greece · Casmyg, Caspofungin Anfarm
- Croatia · Dalvocans, Kaspofungin Ligula Pharma
- Hungary · Caspofungin Demo, Caspofungin Onkogen
- Ireland · Caspofungin, Caspofungin Clonmel
- Iceland · Cancidas, Caspofungin Stada
- Italy · Caspofungi Hikma, Caspofungin Demo
- Liechtenstein · Cancidas
- Lithuania · Caspofungin Sandoz
- Luxembourg · Caspofungine Noridem
- Latvia · Caspofungin Pharmidea
- Malta · Caspofungin Anfarm, Caspofungin Centrient Pharmaceutcials Netherlands
- Netherlands · Caspofungine Cf, Caspofungine Demo
- Norway · Cancidas, Caspofungin Demo S.A.
- Poland · Caspofungin Adamed, Caspofungin Demo
- Portugal · Caspofungina Farmoz, Caspofungina Generis
- Romania · Caspofungină Demo, Caspofungină Kabi
- Slovenia · Kaspofungin, Kaspofungin Teva
- Slovakia · Caspofungin Demo, Caspofungin Sandoz
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Swedish Medical Products Agency (Sweden). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/b58b6d86-6690-41f2-8a70-ab20e0bfac9a GET /v1/drugs/b58b6d86-6690-41f2-8a70-ab20e0bfac9a?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"source": "lakemedelsverket",
"doc_types": [
"EPAR",
"EMA"
],
"se_npl_id": "20041220000153",
"product_page": "https://www.lakemedelsverket.se/sv/sok-lakemedelsfakta/lakemedel?id=20041220000153",
"product_doc_link": "https://www.ema.europa.eu/sv/documents/product-information/cancidas-epar-product-information_sv.pdf"
}See everything about caspofungin.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.